Pre-Workout Supplement, Arrhythmias and Exercise Stress Test
Can a Pre-Workout Supplement Cause Arrhythmias During Physical Exercise in Young Physically Active Individuals? A Randomized, Double-Blind, Placebo-Controlled Study
2 other identifiers
interventional
62
1 country
1
Brief Summary
Pre-workout supplements are widely used by physically active individuals to enhance exercise performance. These products typically contain stimulant substances such as caffeine, beta-alanine, arginine, and tyrosine, which act on the cardiovascular and central nervous systems. Although their ergogenic effects are well established, their safety profile - particularly regarding cardiac arrhythmias during exercise - has not been thoroughly investigated. This study aimed to evaluate whether the acute ingestion of a commercially available multi-ingredient pre-workout supplement (V-FORT® ULTRA, Vitafor, Brazil) could trigger cardiac arrhythmias during a treadmill exercise stress test in young, physically active adults. A randomized, double-blind, placebo-controlled crossover design was used. Participants underwent two exercise stress tests separated by 3 to 10 days: a familiarization test (Day 1) and an intervention test (Day 2), in which they received either the pre-workout supplement or a placebo beverage. Neither the participants nor the research team conducting the test were aware of the allocated intervention until after test completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2026
CompletedFirst Submitted
Initial submission to the registry
September 27, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedOctober 1, 2026
September 1, 2026
6 months
September 27, 2026
September 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of Cardiac Arrhythmias During the Exercise Stress Test
Presence or absence of cardiac arrhythmias identified on continuous 12-lead ECG during the treadmill exercise stress test and the 6-minute post-exercise recovery phase, compared between the pre-workout supplement and placebo conditions.
During the treadmill exercise stress test and throughout the 6-minute post-exercise recovery phase (approximately 30 to 60 minutes per session, on Day 2)
Secondary Outcomes (2)
Haemodynamic Responses During the Exercise Stress Test
At rest, during each stage of the treadmill exercise stress test, at peak effort, and during the 6-minute post-exercise recovery phase on Day 2
Exercise Stress Test Duration
Day 1 (familiarization test) and Day 2 (intervention test), separated by 3 to 10 days
Study Arms (2)
Pre-Workout Supplement
EXPERIMENTALParticipants received a single dose of V-FORT® ULTRA (Vitafor, Brazil), a multi-ingredient pre-workout supplement containing 200 mg caffeine, 2,000 mg beta-alanine, 1,000 mg arginine, 600 mg tyrosine, 300 mg phenylalanine, 415 mg carnitine, 1.9 g carbohydrate, vitamins (C, E, B6, B12) and minerals (sodium, magnesium, zinc); 8 kcal per 8 g sachet. The beverage was consumed up to 3 hours before the treadmill exercise stress test.
Placebo
PLACEBO COMPARATORParticipants received a single dose of Tang® powdered juice (placebo), containing 2.6 g carbohydrate, 2.4 g sugars, 22 mg sodium, 1.1 mg zinc, 23 mg vitamin C, and 2.5 mcg vitamin D, with no stimulant substances. The beverage was prepared to be visually and organoleptically indistinguishable from the active supplement and was consumed up to 3 hours before the treadmill exercise stress test.
Interventions
Single dose of containing 200 mg caffeine, 2,000 mg beta-alanine, 1,000 mg arginine, 600 mg tyrosine, 300 mg phenylalanine, 415 mg carnitine, 1.9 g carbohydrate, vitamins (C, E, B6, B12) and minerals (sodium, magnesium, zinc); 8 kcal per 8 g sachet. Consumed up to 3 hours before the treadmill exercise stress test.
Eligibility Criteria
You may qualify if:
- Age 18 to 30 years Both sexes Physically active, defined as engaging in at least 150 minutes of moderate-intensity physical activity or 75 minutes of vigorous-intensity physical activity per week, assessed by the International Physical Activity Questionnaire (IPAQ) Prior experience with pre-workout supplements (at least one previous use of any stimulant-based pre-workout supplement) No cardiac arrhythmias identified during the familiarization exercise stress test (Day 1)
You may not qualify if:
- Presence of cardiac arrhythmias identified during the familiarization exercise stress test (Day 1) Physical inactivity (below the minimum physical activity thresholds on IPAQ) No prior use of any pre-workout or stimulant supplement Use of medications that may interfere with cardiovascular responses to exercise or supplementation Presence of known cardiovascular, metabolic, or musculoskeletal conditions that contraindicate exercise testing Orthopaedic limitations precluding treadmill exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pro-Coracao
São Paulo, São Paulo, 05021-010, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The study beverage (pre-workout supplement or placebo) was prepared by a study nurse who was not part of the research or outcomes assessment team. The nurse was the only individual aware of the allocation. Participants, the exercise testing team, and the outcomes assessors remained blinded until after complete test execution.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
September 27, 2026
First Posted
October 1, 2026
Study Start
March 3, 2026
Primary Completion
September 3, 2026
Study Completion
September 3, 2026
Last Updated
October 1, 2026
Record last verified: 2026-09